Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.49 |
| ▸ | LPL | P06858 | 6/20 | 0.47 |
| ▸ | LIPG | Q9Y5X9 | 6/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.46 |
| ▸ | TACR2 | P21452 | 2/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SHBG | P04278 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.46 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8987635 | 0.88 | GPR3 (0.57) | GPR3LPLLIPGTRPV1MGLL | |
| SCHEMBL27944146 | 0.82 | GPR3 (0.63) | GPR3LPLLIPGTRPV1MGLL | |
| SCHEMBL28142312 | 0.79 | GPR3 (0.51) | GPR3LPLLIPGTRPV1MGLL | |
| SCHEMBL27955066 | 0.79 | GPR3 (0.51) | GPR3LPLLIPGTRPV1MGLL | |
| SCHEMBL28295158 | 0.79 | GPR3 (0.51) | GPR3LPLLIPGTRPV1MGLL | |
| SCHEMBL26968743 | 0.77 | SKP2 (0.50) | GPR3LPLLIPGTRPV1MGLL | |
| SCHEMBL340040 | 0.76 | PPARA (0.62) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL28287691 | 0.76 | GPR3 (0.51) | GPR3LPLLIPGTRPV1MGLL | |
| SCHEMBL16682972 | 0.76 | GPR3 (0.51) | GPR3LPLLIPGTRPV1MGLL | |
| SCHEMBL26968712 | 0.76 | GPR3 (0.51) | GPR3LPLLIPGTRPV1MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1411067-B1 | POLYMER HAVING UNIQUE OPTICAL PROPERTY | JAPAN SCIENCE & TECH AGENCY (JP) | 2010-09-22 | — | — | EP | disclosed |
| US-7585931-B2 | polymer of dibenzofulvene was polymerized by using an anionic polymerization initiator; solvent resistance; useful as optically active stationary phases for HPLC or polarized- light absorbers | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2009-09-08 | — | — | US | disclosed |
| US-7323538-B2 | Polymer having unique optical property and polymerizable monomer therefor | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-01-29 | — | — | US | disclosed |
| EP-1528070-B1 | OPTICALLY ACTIVE HIGH-MOLECULAR COMPOUNDS | JAPAN SCIENCE & TECH CORP (JP) | 2007-11-28 | — | — | EP | disclosed |
| US-20050234267-A1 | Optically active high-molecular compounds | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2005-10-20 | — | — | US | disclosed |
| EP-1528070-A1 | OPTICALLY ACTIVE HIGH-MOLECULAR COMPOUNDS | Japan Science and Technology Corporation (JP) | 2005-05-04 | — | — | EP | disclosed |
| US-20040132963-A1 | Polymer having unique optical property and polymerizable monomer therefor | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2004-07-08 | — | — | US | disclosed |
| EP-1411067-A1 | POLYMER HAVING UNIQUE OPTICAL PROPERTY AND POLYMERIZABLE MONOMER THEREFOR | Japan Science and Technology Corporation (JP) | 2004-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234267-A1 | Optically active high-molecular compounds | CCNB1, CCNT1, CCND1 | GPR3 371/4885LPL 2723/4885LIPG 3533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.